International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) shares crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.12. International Stem Cell shares last traded at $0.12, with a volume of 8,262 shares changing hands.
International Stem Cell Stock Performance
The firm has a fifty day moving average price of $0.10 and a 200 day moving average price of $0.08. The stock has a market cap of $930,400.00, a PE ratio of -1.45 and a beta of 0.30.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Further Reading
- Five stocks we like better than International Stem Cell
- Bank Stocks – Best Bank Stocks to Invest In
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Why Are Stock Sectors Important to Successful Investing?
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What Are Some of the Best Large-Cap Stocks to Buy?
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
